@article{oai:kanazawa-u.repo.nii.ac.jp:00044484,
 author = {Ietsugu, Ken-ichi and Shimizu, Junzo and Murakami, Shinya and Oda, Makoto and Hayashi, Yoshinobu and Tatsuzawa, Yasuhiko and Kobayashi, Ko-ichi and Sekido, Nobuaki and Arano, Yoshihiko and Takahashi, Atsushi and Watanabe, Yoh and 家持, 健一 and 清水, 淳三 and 村上, 眞也 and 小田, 誠 and 林, 義信 and 龍沢, 泰彦 and 小林, 孝一郎 and 関戸, 伸明 and 荒能, 義彦 and 高橋, 敦 and 渡辺, 洋宇},
 issue = {1},
 journal = {胸部外科 = 日本心臓血管外科学会雑誌, The Japanese journal of thoracic surgery},
 month = {Jan},
 note = {Sixty-seven patients with thymoma were surgically treated during the past 19 years in our department. The 5-year, 10-year and 15-year survival rates of total cases with thymomas were 69.2%, 59.6% and 59.6%, respectively. Survival rates of thymoma with MG and without MG were not significantly different. According to clinical stages in Masaoka's classification, there were significant difference between Stage I and Stag III (p < 0.05), Stage I and Stage IV a (p < 0.01), and Stage I and Stage IV b (p < 0.01). We can conclude that complete resection of thymomas lead to better prognosis, and immunochemotherapy using cyclophosphamide, vincristine and OK-432 are effective., 1, 金沢大学医薬保健研究域医学系},
 pages = {4--8},
 title = {胸腺腫の外科治療},
 volume = {46},
 year = {1993}
}